Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RPL17-C18orf32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TSC22D4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PRPF4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LSMEM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMIM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FLCN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL37A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MPPED1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPIL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC13A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARIH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOLGA8A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on